Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pharmacogenetic studies of Paclitaxel in the treatment of ovarian cancer.
Gréen H, Söderkvist P, Rosenberg P, Mirghani RA, Rymark P, Lundqvist EA, Peterson C. Gréen H, et al. Among authors: lundqvist ea. Basic Clin Pharmacol Toxicol. 2009 Feb;104(2):130-7. doi: 10.1111/j.1742-7843.2008.00351.x. Epub 2008 Dec 16. Basic Clin Pharmacol Toxicol. 2009. PMID: 19143748 Free article.
Targeted therapy in gynecologic cancers: Ready for prime time?
Seoud M, Lundqvist EÅ, Fujiwara K. Seoud M, et al. Among authors: lundqvist ea. Int J Gynaecol Obstet. 2015 Oct;131 Suppl 2:S150-2. doi: 10.1016/j.ijgo.2015.06.012. Int J Gynaecol Obstet. 2015. PMID: 26433672 No abstract available.
Principles of chemotherapy.
Lundqvist EÅ. Lundqvist EÅ. Int J Gynaecol Obstet. 2012 Oct;119 Suppl 2:S151-4. doi: 10.1016/S0020-7292(12)60028-9. Int J Gynaecol Obstet. 2012. PMID: 22999506 No abstract available.
Principles of chemotherapy.
Lundqvist EÅ, Fujiwara K, Seoud M. Lundqvist EÅ, et al. Int J Gynaecol Obstet. 2015 Oct;131 Suppl 2:S146-9. doi: 10.1016/j.ijgo.2015.06.011. Int J Gynaecol Obstet. 2015. PMID: 26433671 Free article. No abstract available.
Survival in endometrial cancer in relation to minimally invasive surgery or open surgery - a Swedish Gynecologic Cancer Group (SweGCG) study.
Borgfeldt C, Holmberg E, Marcickiewicz J, Stålberg K, Tholander B, Lundqvist EÅ, Flöter-Rådestad A, Bjurberg M, Dahm-Kähler P, Hellman K, Hjerpe E, Kjölhede P, Rosenberg P, Högberg T. Borgfeldt C, et al. Among authors: lundqvist ea. BMC Cancer. 2021 Jun 2;21(1):658. doi: 10.1186/s12885-021-08289-3. BMC Cancer. 2021. PMID: 34078319 Free PMC article.
Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial.
du Bois A, Kristensen G, Ray-Coquard I, Reuss A, Pignata S, Colombo N, Denison U, Vergote I, Del Campo JM, Ottevanger P, Heubner M, Minarik T, Sevin E, de Gregorio N, Bidziński M, Pfisterer J, Malander S, Hilpert F, Mirza MR, Scambia G, Meier W, Nicoletto MO, Bjørge L, Lortholary A, Sailer MO, Merger M, Harter P; AGO Study Group led Gynecologic Cancer Intergroup/European Network of Gynaecologic Oncology Trials Groups Intergroup Consortium. du Bois A, et al. Lancet Oncol. 2016 Jan;17(1):78-89. doi: 10.1016/S1470-2045(15)00366-6. Epub 2015 Nov 16. Lancet Oncol. 2016. PMID: 26590673 Clinical Trial.